E-LIB Suche - Ergebnisse für: Vij, Ravi

1

#27. First-in-human evaluation of safety and dosimetry of 6..:

Laforest, Richard ; Ghai, Anchal ; Fraum, Tyler J....
Journal of Bone Oncology. 45 (2024) - p. 100565 , 2024

Link: https://doi.org/10.1016/..

2

#15. Single-cell discovery and multi-omic characterization ..:

Yao, Lijun ; Wang, Julia T. ; Jayasinghe, Reyka G....
Journal of Bone Oncology. 45 (2024) - p. 100553 , 2024

Link: https://doi.org/10.1016/..

3

Plain language summary of the KarMMa-3 study of ide-cel or ..:

Rodriguez-Otero, Paula ; Ailawadhi, Sikander ; Arnulf, Bertrand...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

4

P-263 Treatment patterns and clinical outcomes in multiple ..:

Goldschmidt, Hartmut ; Vij, Ravi ; Kuter, David...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S180-S181 , 2023

Link: https://doi.org/10.1016/..

5

P-264 A phase 1b study of isatuximab and bendamustine for t..:

Goldsmith, Scott ; Slade, Michael ; Fiala, Mark...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S181 , 2023

Link: https://doi.org/10.1016/..

6

Elotuzumab, Pomalidomide and Dexamethasone Maintenance afte..:

Slade, Michael ; Fiala, Mark A ; Kirchmeyer, Marie...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S397-S398 , 2023

Link: https://doi.org/10.1016/..

7

Multi-omic analysis of the tumor microenvironment shows cli..:

Wong, Sandy ; Hamidi, Habib ; Costa, Luciano J....
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

P-299 Survival outcomes in older patients with relapsed/ref..:

Moreau, Philippe ; Vij, Ravi ; Goldschmidt, Hartmut...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S202-S203 , 2023

Link: https://doi.org/10.1016/..

9

Dynamic frailty risk assessment among older adults with mul..:

Mian, Hira ; Wildes, Tanya M. ; Vij, Ravi...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN ..:

Alsina, Melissa ; Dhodapkar, Madhav ; Berdeja, Jesus...
HemaSphere. 7 (2023) S3 - p. e90596a3 , 2023

Link: https://doi.org/10.1097/..

11

CT-356 Idecabtagene Vicleucel (ide-cel) Versus Standard Reg..:

Giralt, Sergio ; Ailawadhi, Sikander ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S527-S528 , 2023

Link: https://doi.org/10.1016/..

12

The Dynamics of Financial Toxicity in Multiple Myeloma:

Fiala, Mark A. ; Silberstein, Alice E. ; Schroeder, Mark A...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 4 - p. 266-272 , 2023

Link: https://doi.org/10.1016/..

13

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Main..:

Slade, Michael ; Fiala, Mark A. ; Kirchmeyer, Marie...
Transplantation and Cellular Therapy. 29 (2023) 12 - p. 764.e1-764.e7 , 2023

Link: https://doi.org/10.1016/..

14

P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS..:

Manier, Salomon ; Rodríguez-Otero, Paula ; Mateos, Maria-Victoria...
HemaSphere. 7 (2023) S3 - p. e3385948 , 2023

Link: https://doi.org/10.1097/..

15

Single-Cell Discovery and Multiomic Characterization of The..:

Yao, Lijun ; Wang, Julia T. ; Jayasinghe, Reyka G....
Cancer Research. 83 (2023) 8 - p. 1214-1233 , 2023

Link: https://doi.org/10.1158/..